These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 25703069)

  • 1. What do we know about phytotherapy of benign prostatic hyperplasia?
    Allkanjari O; Vitalone A
    Life Sci; 2015 Apr; 126():42-56. PubMed ID: 25703069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytotherapy for benign prostatic hyperplasia.
    Wilt TJ; Ishani A; Rutks I; MacDonald R
    Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
    Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
    Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia.
    Krishnamoorthi R; Ganapathy A A; Hari Priya VM; Kumaran A
    J Ethnopharmacol; 2024 Aug; 330():118207. PubMed ID: 38636573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species.
    Jena AK; Vasisht K; Sharma N; Kaur R; Dhingra MS; Karan M
    J Ethnopharmacol; 2016 Aug; 190():33-45. PubMed ID: 27235020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.
    Lee J; Andriole G; Avins A; Crawford ED; Foster H; Kaplan S; Kreder K; Kusek J; McCullough A; McVary K; Meleth S; Naslund M; Nickel JC; Nyberg L; Roehrborn C; Dale Williams O; Barry M
    Clin Trials; 2009 Dec; 6(6):628-36. PubMed ID: 20007408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytotherapy of benign prostatic hyperplasia. A minireview.
    Pagano E; Laudato M; Griffo M; Capasso R
    Phytother Res; 2014 Jul; 28(7):949-55. PubMed ID: 25165780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
    Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A
    Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uvaria rufa Blume attenuates benign prostatic hyperplasia via inhibiting 5α-reductase and enhancing antioxidant status.
    Buncharoen W; Saenphet K; Saenphet S; Thitaram C
    J Ethnopharmacol; 2016 Dec; 194():483-494. PubMed ID: 27732901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytotherapeutic agents in the treatment of benign prostatic hyperplasia.
    Dreikorn K
    Curr Urol Rep; 2000 Aug; 1(2):103-9. PubMed ID: 12084323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pygeum africanum for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R; Rutks I; Stark G
    Cochrane Database Syst Rev; 2002; 1998(1):CD001044. PubMed ID: 11869585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.
    Elterman DS; Lawrentschuk N; Guns E; Hersey K; Adomat H; Wood CA; Fleshner N
    J Urol; 2010 May; 183(5):2085-9. PubMed ID: 20303529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Benign Prostatic Hyperplasia by Natural Drugs.
    Csikós E; Horváth A; Ács K; Papp N; Balázs VL; Dolenc MS; Kenda M; Kočevar Glavač N; Nagy M; Protti M; Mercolini L; Horváth G; Farkas Á; On Behalf Of The Oemonom
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of animal and human studies for management of benign prostatic hyperplasia with natural products: perspective of new pharmacological agents.
    Azimi H; Khakshur AA; Aghdasi I; Fallah-Tafti M; Abdollahi M
    Inflamm Allergy Drug Targets; 2012 Jun; 11(3):207-21. PubMed ID: 22512478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [With alpha blockers, finasteride and nettle root against benign prostatic hyperplasia. Which patients are helped by conservative therapy?].
    Vahlensieck W
    MMW Fortschr Med; 2002 Apr; 144(16):33-6. PubMed ID: 12043098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia.
    Dreikorn K
    World J Urol; 2002 Apr; 19(6):426-35. PubMed ID: 12022711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal plants used for menstrual disorders in Latin America, the Caribbean, sub-Saharan Africa, South and Southeast Asia and their uterine properties: a review.
    van Andel T; de Boer HJ; Barnes J; Vandebroek I
    J Ethnopharmacol; 2014 Sep; 155(2):992-1000. PubMed ID: 24975195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of benign prostatic hyperplasia.
    Edwards JL
    Am Fam Physician; 2008 May; 77(10):1403-10. PubMed ID: 18533373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
    Coulson S; Rao A; Beck SL; Steels E; Gramotnev H; Vitetta L
    Complement Ther Med; 2013 Jun; 21(3):172-9. PubMed ID: 23642948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbs for benign prostatic hyperplasia.
    Dvorkin L; Song KY
    Ann Pharmacother; 2002 Sep; 36(9):1443-52. PubMed ID: 12196065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.